For: | Jin LY, Wang K, Xu BT. High metabolic dysfunction-associated steatotic liver disease prevalence in type 2 diabetes: Urgent need for integrated screening and lifestyle intervention. World J Hepatol 2025; 17(1): 103409 [PMID: 39871905 DOI: 10.4254/wjh.v17.i1.103409] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v17/i1/103409.htm |
Number | Citing Articles |
1 |
Ge-yao Qi, Fei Wang, Yuan-bo Shi, Juan Feng, Jin Xu. Analysis of postprandial time trends and influencing factors of blood glucose and insulin in type 2 diabetes mellitus (T2DM) with metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective study based on propensity score matching (PSM). Acta Diabetologica 2025; doi: 10.1007/s00592-025-02503-5
|
2 |
Jéssica Silva Salarini, Lygia Nestal Barroso, Jade Veloso Freitas, Nathalie Carvalho Leite, Tatiana Pereira de Paula, Patrícia de Carvalho Padilha, Wilza Arantes Ferreira Peres. The Brazilian traditional dietary pattern was associated with a lower risk of advanced steatosis in patients with metabolic dysfunction-associated steatotic liver disease. Nutrition Research 2025; 139: 66 doi: 10.1016/j.nutres.2025.04.012
|
3 |
Rui Chen, Ying Zhou, Minzhi Xu, Yanhong Gong, Wenfei Xia, Xiaoxv Yin. Association between multifactorial control and excess risk of liver diseases in type 2 diabetes: a prospective cohort study. BMJ Open Diabetes Research & Care 2025; 13(5): e005336 doi: 10.1136/bmjdrc-2025-005336
|